References

Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status. Infect Genet Evol. 2020; 83:(2020) https://doi.org/10.1016/j.meegid.2020.104327

How South Korea flattened the coronavirus curve with technology. 2020. https://tinyurl.com/yd3q6nd9 (accessed 28 September 2020)

Cheng VCC, Lau SKP, Woo PCY Severe Acute Respiratory Syndrome Coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007; 20:(4)660-694 https://doi.org/10.1128/CMR.00023-07

De Wit E, Van Doremalen N, Falzarano D SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14:(8)523-534 https://doi.org/10.1038/nrmicro.2016.81

Dhama K, Khan S, Tiwari R Coronavirus disease 2019–COVID-19. Clin Microbiol Rev. 2020; 33:(4)e00028-20 https://doi.org/10.1128/CMR.00028-20

Du L, He Y, Zhou Y The spike protein of SARS-CoV — a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009; 7:226-236 https://doi.org/10.1038/nrmicro2090

GISAID. Genomic epidemiology of HCoV. 2020. https://www.gisaid.org/ (accessed 28 September 2020)

Guan Y, Peiris JS, Zheng B Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet. 2004; 363:(9403)99-104 https://doi.org/10.1016/s0140-6736(03)15259-2

Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect. 2020; 35 https://doi.org/10.1016/j.nmni.2020.100679

Liang X. Is COVID-19 more severe in older men?. Postgrad Med J. 2020; 96

Liu P, Jiang JZ, Wan XF Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?. PLoS Pathog. 2020; 16:(5) https://doi.org/10.1371/journal.ppat.1008421

London School of Hygience and Tropical Medicine. S1E28: developing a COVID-19 vaccine-are we close? (Podcast). 2020. https://tinyurl.com/y2ytyhe8 (accessed 28 September 2020)

Lu L, Zhong W, Bian Z A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: a systematic review and meta-analysis. J Infect. 2020; 81:(4)e18-e25 https://doi.org/10.1016/j.jinf.2020.07.002

Mubarak A, Alturaiki W, Hemida MG. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): infection, immunological response, and vaccine development. J Immunol Res. 2019; https://doi.org/10.1155/2019/6491738

Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J. 2020; 19:410-417 https://doi.org/10.17179/excli2020-1167

Otter JA, Donskey C, Yezli S Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016; 92:(3)235-250 https://doi.org/10.1016/j.jhin.2015.08.027

Park M, Thwaites R, Openshaw P. COVID-19: lessons from SARS and MERS. Eur J Immunol. 2020; 50:(3)308-311 https://doi.org/10.1002/eji.202070035

Public Health England. Excess weight and COVID-19: insights from new evidence. 2020a. https://tinyurl.com/yy2zpfml (accessed 9 October 2020)

Public Health England. Beyond the data: understanding the impact of COVID-19 on BAME groups. 2020b. https://tinyurl.com/y797mv8c (accessed 9 October 2020)

Warren CJ, Sawyer SL. How host genetics dictates successful viral zoonosis. PLoS Biol. 2019; 17:(4) https://doi.org/10.1371/journal.pbio.3000217

Wong MC, Javornik Creegen SJ, Ajami NJ, Petrosino JF. Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv. 2020; https://doi.org/10.1101/2020.02.07.939207

World Health Organization. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases. 2004. https://tinyurl.com/y2xbqygg (accessed 28 September 2020)

World Health Organization. Health topic zoonoses. 2020a. https://tinyurl.com/y5adsqbb (accessed 28 September 2020)

World Health Organization. Emergencies preparedness, response-novel Coronavirus. 2020b. https://tinyurl.com/uvqqk9g (accessed 28 September 2020)

World Health Organization. Coronavirus disease (COVID-19) situation report-189. 2020c. https://tinyurl.com/y3ronkgn (accessed 27 September 2020)

How the zoonotic origins of SARS-CoV-2 ensure its survival as a human disease

02 November 2020
Volume 25 · Issue 11

Abstract

In December 2019, a new species of coronavirus (SARS-CoV-2) was identified in a number of patients presenting with pneumonias of unknown aetiology in WuHan Province, China. Early epidemiological indications were of a zoonotic origin: many of the initial patients confirmed contact with a local wet market and the genomic sequencing showed similar characteristics with coronaviruses known to be carried by bats. The theory of subsequent human to human transmission became evident once global epidemiological reporting of COVID infection was established. Confirmation of the origins of infections caused by SARS-CoV-2 was enabled by the early sharing of the initial genomic sequence by China in January 2020 and since developed collaboratively on a globally accessible database, supported by the World Health Organization (https://tinyurl.com/rj32fp3).

Four years after the last emergent epidemic of zoonotic SARS-coronavirus in 2003, researchers at the University of Hong Kong asked if the world was ready for the re-emergence of SARS (Cheng et al, 2007).

Despite over 4000 publications since 2003, the assessment highlighted the persistent gaps in scientific achievement relating to the perception of zoonotic coronaviruses. Up until 6 months ago, this evaluation in the face of anticipated further epidemics of a coronavirus still held true (Cheng et al, 2007; Mubarak et al, 2019).

This article-the second in a series on the science behind the pandemic-explores the opportunities for learning from previous human epidemics of coronaviruses and highlights the unintended consequences of underestimating the evolutionary aptitude of this family of viruses to ensure species survival into the next generation.

Zoonoses may be bacterial, viral or parasitic and are defined as any disease or infection that is naturally transmissible from a vertebrate species to humans (WHO, 2020). Zoonoses, as with many infections, can be transmitted through direct contact or indirectly via food, water or the environment. It is estimated that <0.1% of animal viruses are zoonotic with some inherent ability to replicate in humans (Warren and Sawyer, 2019).

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month